We are live on
!
Find out more
HT
Hefren-Tillotson Portfolio holdings
AUM
$523M
1-Year Est. Return
4.13%
This Fund
S&P 500
This Quarter
Est. Return
+2.05%
1 Year Est. Return
+4.13%
3 Year Est. Return
+40.01%
5 Year Est. Return
+56.62%
10 Year Est. Return
–
AUM
$293M
AUM Growth
+$10.6M
(+3.8%)
Cap. Flow
+$4.74M
Cap. Flow
% of AUM
1.62%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
11
New
–
Increased
7
Reduced
3
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Value ETF
VTV
|
+$3.72M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$598K |
| 3 |
WisdomTree US MidCap Fund
EZM
|
+$267K |
| 4 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$156K |
| 5 |
iShares MSCI EAFE Small-Cap ETF
SCZ
|
+$150K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$134K |
| 2 |
Columbia Emerging Markets Consumer ETF
ECON
|
+$125K |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$48.8K |
| 4 |
Vanguard Dividend Appreciation ETF
VIG
|
+$44.8K |
Sector Composition
| Rank | Sector | Weight |
|---|
Similar funds
SM
GH
HAM
FC
FC
VR
MCM
TM
Hefren-Tillotson's Q1 2014 Portfolio in Review
As of Q1 2014, Hefren-Tillotson held 11 positions worth $293M, up 3.8% from $282M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Hefren-Tillotson's Q1 2014 filing shows 7 increased, 3 reduced and 1 closed positions. The largest sale was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $134K.
- Hefren-Tillotson added most to Vanguard Value ETF in Q1 2014, an estimated $3.72M increase.
- Hefren-Tillotson's biggest Q1 2014 reduction was JP Morgan Alerian MLP Index ETN 5/24/24, cutting an estimated $134K.
- Hefren-Tillotson fully exited Columbia Emerging Markets Consumer ETF in Q1 2014, selling an estimated $125K.
- Hefren-Tillotson's ten largest holdings make up 100% of its $293M portfolio in Q1 2014.
- Hefren-Tillotson opened 0 new positions and closed 1 in Q1 2014.
- Hefren-Tillotson's portfolio value rose 3.8% quarter-over-quarter to $293M.
Based on Hefren-Tillotson's 13F filing for Q1 2014, filed 5 May 2014.